Literature DB >> 21494466

Neurological soft signs, cognitive dysfunction and ventricular brain ration in schizophrenics.

N Lal1, S C Tiwari, S Srivastava, A Khalid, N Kohli.   

Abstract

An association between cognitive dysfunction, neurological soft signs, enlarged brain ventricles and widened cortical sulci has been reported in schizophrenia. The present work aimed to study the relevance of positive and negative dichotomy with relation to neuropsychological performance of the schizophrenic patients, and the presence of neurological soft signs. In 23 schizophrenics patients diagnosed according to DSM-III-R of which 14 were of positive subtype and 9 were of negative subtype. At least one neurological soft sign was present in all the patients. The positive group had higher WMS and IQ scores and lower BGT scores than the negative group. Negative, correlation was seen for WMS and BGT scores with Ventricular Brain Ratio (VBR), and the soft signs showed positive correlation in the positive subtype only.

Entities:  

Keywords:  Schizophrenia; negative subtype; neurological soft signs; neuropsychological tests; positive subtype; ventricular brain ratio

Year:  1998        PMID: 21494466      PMCID: PMC2965842     

Source DB:  PubMed          Journal:  Indian J Psychiatry        ISSN: 0019-5545            Impact factor:   1.759


  21 in total

Review 1.  Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia.

Authors:  H E Spohn; M E Strauss
Journal:  J Abnorm Psychol       Date:  1989-11

Review 2.  Molecular pathology of schizophrenia: more than one disease process?

Authors:  T J Crow
Journal:  Br Med J       Date:  1980-01-12

3.  Lateral cerebral ventricular enlargement in chronic schizophrenia.

Authors:  D R Weinberger; E F Torrey; A N Neophytides; R J Wyatt
Journal:  Arch Gen Psychiatry       Date:  1979-07

4.  Schizophrenia with good and poor outcome. III: Neurological 'soft' signs, cognitive impairment and their clinical significance.

Authors:  T Kolakowska; A O Williams; K Jambor; M Ardern
Journal:  Br J Psychiatry       Date:  1985-04       Impact factor: 9.319

5.  Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities.

Authors:  N C Andreasen; J C Ehrhardt; V W Swayze; R J Alliger; W T Yuh; G Cohen; S Ziebell
Journal:  Arch Gen Psychiatry       Date:  1990-01

6.  Structural abnormalities in the frontal system in schizophrenia. A magnetic resonance imaging study.

Authors:  N Andreasen; H A Nasrallah; V Dunn; S C Olson; W M Grove; J C Ehrhardt; J A Coffman; J H Crossett
Journal:  Arch Gen Psychiatry       Date:  1986-02

7.  Neurological soft signs and psychopathology. I. Findings in schizophrenia.

Authors:  S M Cox; A M Ludwig
Journal:  J Nerv Ment Dis       Date:  1979-03       Impact factor: 2.254

8.  Lateral ventricular size in schizophrenia: relationship to the disease process and its clinical manifestations.

Authors:  D G Owens; E C Johnstone; T J Crow; C D Frith; J R Jagoe; L Kreel
Journal:  Psychol Med       Date:  1985-02       Impact factor: 7.723

9.  Schizophrenia with good and poor outcome. II: Cerebral ventricular size and its clinical significance.

Authors:  A O Williams; M A Reveley; T Kolakowska; M Ardern; B M Mandelbrote
Journal:  Br J Psychiatry       Date:  1985-03       Impact factor: 9.319

10.  Cerebral ventricular size and cognitive impairment in chronic schizophrenia.

Authors:  E C Johnstone; T J Crow; C D Frith; J Husband; L Kreel
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

View more
  2 in total

1.  An overview of Indian research in schizophrenia.

Authors:  Parmanand Kulhara; Ruchita Shah; K R Aarya
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

2.  The evolution of Indian psychiatric research: An examination of the early decades of the Indian Journal of Psychiatry.

Authors:  Rajiv Radhakrishnan; Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.